Zdrowie i gospodarka · 21/06/2019
FDA Releases Draft Guidance on Opioid Analgesic Drugs
The FDA has published a draft guidance outlining its benefit-risk assessment framework for opioid analgesic drugs, aiming to standardize the evaluation process for new applications.
Source: Federal Register — Food and Drug AdministrationOpen original release →